Format

Send to

Choose Destination
J Mol Cell Cardiol. 2015 Nov;88:73-81. doi: 10.1016/j.yjmcc.2015.09.005. Epub 2015 Sep 24.

Characterization of the cardiac succinylome and its role in ischemia-reperfusion injury.

Author information

1
Systems Biology Center, NHLBI, NIH, Bethesda, MD, United States.
2
Proteomics Core Facility, NHLBI, NIH, Bethesda, MD, United States.
3
Center for Molecular Medicine, NHLBI, NIH, Bethesda, MD, United States.
4
Systems Biology Center, NHLBI, NIH, Bethesda, MD, United States. Electronic address: murphy1@nhlbi.nih.gov.

Abstract

Succinylation refers to modification of lysine residues with succinyl groups donated by succinyl-CoA. Sirtuin5 (Sirt5) is a mitochondrial NAD(+)-dependent deacylase that catalyzes the removal of succinyl groups from proteins. Sirt5 and protein succinylation are conserved across species, suggesting functional importance of the modification. Sirt5 loss impacts liver metabolism but the role of succinylation in the heart has not been explored. We combined affinity enrichment with proteomics and mass spectrometry to analyze total succinylated lysine content of mitochondria isolated from WT and Sirt5(-/-) mouse hearts. We identified 887 succinylated lysine residues in 184 proteins. 44 peptides (5 proteins) occurred uniquely in WT samples, 289 (46 proteins) in Sirt5(-/-) samples, and 554 (133 proteins) were common to both groups. The 46 unique proteins in Sirt5(-/-) heart participate in metabolic processes such as fatty acid β-oxidation (Eci2) and branched chain amino acid catabolism, and include respiratory chain proteins (Ndufa7, 12, 13, Dhsa). We performed label-free analysis of the peptides common to WT and Sirt5(-/-) hearts. 16 peptides from 9 proteins were significantly increased in Sirt5(-/-) by at least 30%. The adenine nucleotide transporter 1 showed the highest increase in succinylation in Sirt5(-/-) (108.4 fold). The data indicate that succinylation is widespread in the heart and enriched in metabolic pathways. We examined whether the loss of Sirt5 would impact ischemia-reperfusion (I/R) injury and we found an increase in infarct size in Sirt5(-/-) hearts compared to WT littermates (68.5(+)/-1.1% Sirt5(-/-) vs 39.6(+)/(-) 6.8% WT) following 20min of ischemia and 90-min reperfusion. We further demonstrate that I/R injury in Sirt5(-/-) heart is restored to WT levels by pretreatment with dimethyl malonate, a competitive inhibitor of succinate dehydrogenase (SDH), implicating alteration in SDH activity as causative of the injury.

KEYWORDS:

Cardiac; Ischemia–reperfusion; Sirt5; Succinate; Succinylation

PMID:
26388266
PMCID:
PMC4780049
DOI:
10.1016/j.yjmcc.2015.09.005
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center